Few debates in knee arthroplasty spark as much polite-but-pointed hallway chatter as the fixation question: cemented or ...

In spine surgery, measuring success isn’t always as simple as “X-rays look straighter, job well done.” Deformity surgeons ...

In June 2025, Cerapedics secured FDA premarket approval for its PearlMatrix™ P-15 Peptide Enhanced Bone Graft.

Integra LifeSciences Holdings Corporation reported $415.6 million in sales and ($512.674) million in operating losses for the ...

Orthofix Medical, Inc. reported $203.121 million in sales and ($16,003) million in operating losses for the quarter ending ...

According to a new meta-analysis in the July 13, 2025, Journal of Experimental Orthopaedics, you’ll need to perform somewhere ...

A worried parent, a stoic (or not-so-stoic) child, and a pediatric back pain story that may or may not rival an epic saga.

In an industry where everyone talks about “disrupting” spine, Demetra Holding S.p.A. might actually be doing it.

CONMED’s 2Q25 numbers are in, and the picture is a mix of solid topline growth, orthopedic momentum, and some capital-market ...

Stryker Corporation is in growth mode—again. In its Q2 2025 earnings call, CEO Kevin Lobo and VP of Finance and Investor ...

It's time to stop casually watching Alphatec Holdings, Inc. and start paying attention—they're not just growing, they’re ...

In the land of blues, barbecue, and biomedical hustle, Memphis is turning up the volume on medtech innovation.